CSL shares have fallen almost 40% in 2025. Investors are now asking if the worst is already behind the stock. CSL shares fell nearly 40% in 2025 due to underwhelming profit guidance, elevated costs, ...
Should you be buying the dip? Let's find out. CSL shares crashed 39% during 2025 to $172.65 as management slashed revenue and profit growth guidance, signalling that the biotherapeutics giant's next ...
CSL Behring's Andembry can be used to prevent recurrent attacks of hereditary angioedema (HAE) by the NHS, according to finalised guidance from reimbursement authority NICE. The just-published ...
A 1972 BMW 3.0 CSL, one of the most iconic homologation specials in the automaker’s history, is now up for auction via RM Sotheby’s. This Italian-market, second-series example has been meticulously ...
CSL has said that with flu jab rates in the US down between 12% and 14% this year, it has decided to delay the planned spinout of its Seqirus vaccines business and cut its profit forecast for the ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Michal studies Automotive Journalism at Coventry University in the UK, and has been writing for CarBuzz since March 2025. He was nominated for student culture piece of the year recently and has been ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results